Company
TruScreen Group Limited
Headquarters: Auckland, New Zealand
CEO: Ms. Juliet Hull M.B.A.
Market Cap
NZ$10.1 Million
NZD as of Jan. 1, 2024
US$6.4 Million
TruScreen Group Limited Categories
New Zealand Healthcare Medical DevicesNew Zealand Healthcare New Zealand Medical Devices
Top Competitors by Market Capitalization
Industry: Medical Devices
| Company | Market Cap (USD) |
|---|---|
| Abbott | $192.67 B |
| Stryker Corporation | $113.24 B |
| Medtronic | $111.60 B |
| Boston Scientific Corporation | $85.22 B |
| Shenzhen Mindray Bio-Medical Electronics Co. Ltd | $49.33 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
Truscreen Group Limited, together with its subsidiaries, develops, manufactures, and sells cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, and internationally. The company offers the TruScreen cervical cancer screening system, a medical device for detecting the presence of precancerous and cancerous tissue on the cervix in real time. The company was formerly known as TruScreen Limited and changed its name to Truscreen Group Limited in August 2020. Truscreen Group Limited was incorporated in 2013 and is headquartered in Auckland, New Zealand.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
TruScreen Group Limited has the following listings and related stock indices.
Stock: NZX: TRU wb_incandescent
Stock: ASX: TRU wb_incandescent